Digestive Enzymes
Digestive Enzyme Complex
Enzyme blend that supports digestion of proteins, fats, carbohydrates, and fiber, reducing bloating and improving nutrient absorption.
Digestive enzyme supplements contain a blend of enzymes that help break down foods your body may struggle to digest on its own. Common enzymes include proteases (proteins), lipases (fats), amylases (carbohydrates), and specialty enzymes like lactase and alpha-galactosidase. Useful for occasional digestive discomfort, food intolerances, and age-related enzyme decline.
Mechanisms of Action
Protein Digestion
Proteases break down proteins into amino acids
Fat Digestion
Lipase breaks down fats for absorption
Carbohydrate Digestion
Amylase and specialty enzymes break down carbs
Recommended Dose
1-2 capsules with meals (varies by product)
Loading: Not required
Optimal Timing
- At beginning of meals or just before eating
Take with food
Best Form
Broad-spectrum enzyme blend capsules
Alternatives: Specific enzymes (lactase, alpha-galactosidase), Chewables
Choose based on specific needs: full-spectrum for general use, lactase for dairy, alpha-galactosidase (Beano) for beans/legumes.
Duration
Minimum: as needed
Optimal: as needed
Cycling: Not required
Note: MUST be taken with meals to work. Taking on empty stomach provides no digestive benefit.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Reduced Bloating
Less gas and bloating after meals
Better Digestion
Improved comfort after eating
Food Tolerance
Better tolerance of trigger foods
Generally safe; consult doctor
Prescription enzymes may be more appropriate
Who Should NOT Take This
- Active ulcers or gastritis (some enzymes may irritate)
- Allergy to source (pineapple for bromelain, papaya for papain)
Drug Interactions
Bromelain/papain may have mild antiplatelet effects — may affect platelet aggregation or vitamin K-dependent clotting factors, altering anticoagulant efficacy
May affect carbohydrate absorption timing
Possible Side Effects
Tip: Reduce dose
Tip: Take with food (not on empty stomach)
Tip: Switch to capsules
Warnings
- Not a cure for chronic digestive diseases
- If symptoms persist, see a doctor
- Must be taken with meals to work
Probiotics
complementaryEnzymes break down food; probiotics support gut flora
Comprehensive digestive support
Betaine HCl
complementaryHCl supports stomach acid; enzymes support breakdown
Full digestive support for low-acid conditions
Ox Bile
complementaryBile emulsifies, lipase digests fats
Complete fat digestion support
Top studies from 40+ peer-reviewed papers
Noble CCA et al. • The American journal of clinical nutrition (2021)
“Several biological and psychosocial interventions show promise in improving outcomes in children following hospitalization for SAM and require further exploration in larger randomized mortality trials.”
Key Findings:
- Compared with standard care, pancreatic enzyme supplementation reduced inpatient mortality (37.8% compared with 18.6%, P < 0.05).
- In meta-analysis there was some evidence that prebiotics or synbiotics reduced mortality (RR: 0.72; 95% CI: 0.51, 1.00; P = 0.049).
- Psychosocial stimulation reduced mortality in meta-analysis of the 2 trials reporting deaths (RR: 0.36; 95% CI: 0.15, 0.87), and improved neurodevelopmental scores in ≥1 domain in all studies.
Hirota M et al. • Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2024)
“Despite a high risk of bias due to various reference standards, this updated meta-analysis and the utility assessment by a decision tree showed the utility of serum amylase or lipase levels more than 3 times ULN measured 2-4 h after ERCP for predicting PEP.”
Key Findings:
- Meta-analysis of eight studies (4389 participants) showed a pooled sensitivity of 71.1% (95% confidence interval [CI] 56.1-82.5) and pooled specificity of 91.2% (95% CI 85.9-94.6) for the serum amylase cut-off value at 3 times the upper limit of normal (ULN).
- Another meta-analysis of five studies (1970 participants) showed a pooled sensitivity of 85.8% (95% CI 61.9-95.7) and pooled specificity of 85.3% (95% CI 81.9-88.1) for the serum lipase cut-off value at 3 times ULN.
- Despite a high risk of bias due to various reference standards, this updated meta-analysis and the utility assessment by a decision tree showed the utility of serum amylase or lipase levels more than 3 times ULN measured 2-4 h after ERCP for predicting PEP.
Zhou Y et al. • Frontiers in public health (2022)
“PE elevation was a common phenomenon in patients with COVID-19, and was associated with poor clinical outcomes.”
Key Findings:
- In addition, the subgroup analysis revealed that although PE elevated to > 3 × upper normal limit (ULN) was significantly related to the mortality (OR = 4.4, 2.1-9.4), it seemed that mild elevation of PE to 1-3 ULN also had a considerable risk of mortality (OR = 2.3, 1.5-3.5).
- PE elevation was a common phenomenon in patients with COVID-19, and was associated with poor clinical outcomes.
- However, due to the limited numbers of included studies, the result of our study still needed to be validated.
Kawamoto M et al. • International journal of cancer (2022)
“Rare variants in CPB1 and CPA1 that induce ER stress are associated with increased odds of developing pancreatic cancer.© 2021 UICC.”
Key Findings:
- Of the 1385 patients with PDAC, 0.65% were found to harbor an ER stress-inducing variant in CPA1 or CPB1, compared to 0.17% of the 64 026 controls (odds ratio [OR]: 3.80 [1.92-7.51], P = .0001).
- ER stress-inducing variants in the CPA1 gene were identified in 4 of 1385 PDAC cases vs 77 of 64 026 gnomAD controls (OR: 2.4 [0.88-6.58], P = .087), and variants in CPB1 were detected in 5 of 1385 cases vs 33 of 64 026 controls (OR: 7.02 [2.74-18.01], P = .0001).
- Meta-analysis demonstrated strong associations for pancreatic cancer and ER-stress inducing variants for both CPA1 (OR: 3.65 [1.58-8.39], P < .023) and CPB1 (OR: 9.51 [3.46-26.15], P < .001).
Ul Ain Q et al. • World journal of gastroenterology (2021)
“Although patients with CP had similar calorie intake to controls, studies that analysed the contribution of alcohol to energy intake showed that patients with CP consumed fewer non-alcohol calories than healthy controls.”
Key Findings:
- Those with alcohol-related CP consumed more mean (standard deviation) calories than CP patients with a non-alcohol aetiology [2642 (1090) kcal and 1372 (394) kcal, respectively, P = 0.046], as well as more protein, fat, but not carbohydrate.
- Although patients with CP had similar calorie intake to controls, studies that analysed the contribution of alcohol to energy intake showed that patients with CP consumed fewer non-alcohol calories than healthy controls.
- A high calorie intake, made up to a large degree by alcohol, may in part contribute to poor nutritional status in CP.
Study Type Distribution
Goals This Supplement Supports
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.